Dr. Donn Alan Latour, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7070 E Dr N, Battle Creek, MI 49014 Phone: 269-660-1670 Fax: 269-660-0666 |
Dr. Andrea Clare Van Ee, DNP, FNP-BC Dermatology - MOHS-Micrographic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7070 E Dr N, Battle Creek, MI 49014 Phone: 269-660-1670 |
John M Chadwick, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 203 Capital Ave Ne, Battle Creek, MI 49017 Phone: 269-968-1654 Fax: 269-968-0760 |
News Archive
Ending Preventable Maternal Mortality is a global initiative with the ultimate goal of ending preventable maternal mortality to support achievement of Sustainable Development Goals targets to attain an average global maternal mortality ratio of less than 70 per 100 000 live births by 2030.
Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Gemzar (gemcitabine HCl) for use in the treatment of women living with recurrent ovarian cancer.
The opioid epidemic has had devastating effects on families in rural communities, places where both maternity care and substance use treatment are limited.
Decreased collagen levels might make some women more susceptible to pelvic organ prolapse and urinary incontinence, according to a new study by physicians at Temple University School of Medicine and Temple University Hospital. The study, "Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinary incontinence," appears in a recent issue of the American Journal of Obstetrics and Gynecology.
› Verified 4 days ago